Cargando…
Drug-Induced Hyperglycemia as a Potential Contributor to Translational Failure of Uncompetitive NMDA Receptor Antagonists
Hyperglycemia is a comorbidity in 60–80% of stroke patients; nevertheless, neuroprotective drugs like NMDA receptor (NMDAR) antagonists are typically assessed in normoglycemic animals at the preclinical stage before they are approved to enter clinical trials. Interestingly, as a possible explanation...
Autores principales: | Wang, Eric Yuhsiang, Lai, Ted Weita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Neuroscience
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721515/ https://www.ncbi.nlm.nih.gov/pubmed/34862204 http://dx.doi.org/10.1523/ENEURO.0346-21.2021 |
Ejemplares similares
-
The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users
por: Shram, Megan J., et al.
Publicado: (2023) -
TAT peptide at treatment-level concentrations crossed brain endothelial cell monolayer independent of receptor-mediated endocytosis or peptide-inflicted barrier disruption
por: Wu, Meng-Chih, et al.
Publicado: (2023) -
Blood–Brain Barrier Disruption in Preclinical Mouse Models of Stroke Can Be an Experimental Artifact Caused by Craniectomy
por: Liu, Che-Wei, et al.
Publicado: (2022) -
A mechanism of uncompetitive inhibition of the serotonin transporter
por: Bhat, Shreyas, et al.
Publicado: (2023) -
NMDA Receptors on Dopaminoceptive Neurons Are Essential for Drug-Induced Conditioned Place Preference123
por: Sikora, Magdalena, et al.
Publicado: (2016)